A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration
Postepy Dermatol Alergol
.
2022 Dec;39(6):1171-1173.
doi: 10.5114/ada.2022.122609.
Epub 2022 Dec 22.
Authors
Koremasa Hayama
1
2
,
Satoshi Izaki
1
,
Kentaro Hayashi
3
,
Yusuke Kurosawa
3
,
Shiho Yamada
3
,
Tetsuo Shimizu
3
,
Yasuhiro Gon
2
3
,
Hideki Fujita
1
Affiliations
1
Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
2
Center for Allergy, Nihon University Itabashi Hospital, Tokyo, Japan.
3
Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
PMID:
36686023
PMCID:
PMC9837585
DOI:
10.5114/ada.2022.122609
No abstract available